Allurion Technologies (ALUR) “announced a strategic distribution partnership with Minogue Medical Inc., a leading Canadian medical device company specializing in bariatric and obesity care. This new partnership draws upon Minogue Medical’s 40-year experience in the Canadian market and reflects Allurion’s commitment to establishing a new standard of care in obesity management focused on metabolically healthy weight loss.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALUR:
- Allurion Technologies submits PMA to FDA, announces additional AUDACITY data
- Buy Rating on Allurion Technologies: Strategic Positioning and Growth Potential
- Allurion Technologies Earnings Call: Transition and Growth
- Allurion Technologies Reports Q1 2025 Financial Results
- Allurion Technologies: Strong Buy Rating Backed by Promising Financial Performance and Strategic Initiatives